Companies: 10,795·Total market cap: $144.5T
GoodRx Holdings, Inc.

GoodRx Holdings, Inc.

GDRXNASDAQHealthcare● Active
$2.65
$-0.20(-7.02%)
Market Cap$918568374
P/E Ratio
52W High$5.81
52W Low$1.77
Overview

GoodRx Holdings, Inc. (GDRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GDRX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$0.06gdrx eps ttm · gdrx earnings per shareEarnings history
PE Ratio (TTM)45.2×gdrx pe ratio ttm · gdrx price to earningsPE Ratio deep dive
Revenue (TTM)$787.9Mgdrx revenue ttm · gdrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes gdrx pay dividends · gdrx dividend yieldDividend history
Shares Outstanding356.3Mgdrx shares outstanding · gdrx floatShares outstanding history
Next EarningsAug 5, 2026Est.gdrx earnings date · gdrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$796.9M▲ +0.57% YoY
202320242025
goodrx holdings, inc. revenue · gdrx revenue 2025
FY 2025Net Income$30.4M▲ +85.72% YoY
202320242025
goodrx holdings, inc. net income · gdrx profit 2025
FY 2025EPS$0.09▲ +100.94% YoY
202320242025
gdrx eps · goodrx holdings, inc. earnings per share 2025
TTM:Revenue: $787.9MNet Income: $20.6MEPS: $0.06View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold24 analystsis gdrx a buy · gdrx analyst rating
Strong Buy
0
Buy
10
Hold
13
Sell
1
Strong Sell
0
12-Month Price Target
$2.75Low
$2.65Current
$3.25Avg Target22.64% upside
$4.00High
gdrx price target · gdrx 12 month forecast

Total: 24 · Buy rate: 41.7%

The GDRX analyst consensus is Hold, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month price target is $3.25, representing +22.64% upside from the current price of $2.65.

Stock Performance

Full History
1D-7.02%
1W-10.17%
1M-9.25%
3M+16.23%
YTD-2.21%
1Y-35.52%
5Y-93.22%

About GoodRx Holdings, Inc.

CEOWendy Barnes
IPO DateSep 23, 2020
Employees738
CountryUS
Websitegoodrx.com

GoodRx Holdings, Inc. through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company op…

what is goodrx holdings, inc. · gdrx stock overview · goodrx holdings, inc. company profile · who is goodrx holdings, inc. ceo · gdrx NASDAQ · goodrx holdings, inc. headquarters · goodrx holdings, inc. business segments

About Stock Overview & Key Data

GoodRx Holdings, Inc. (GDRX) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Sep 23, 2020. As of the latest trading session, GDRX stock price is $2.65, with a market capitalization of $918.6M. The stock has returned -35.52% over the past 12 months and -2.21% year-to-date.

According to 24 Wall Street analysts, the consensus rating for GoodRx Holdings, Inc. stock is Hold, with an average 12-month price target of $3.25. In fiscal year 2025, GoodRx Holdings, Inc. reported revenue of $796.9M and net income of $30.4M. For detailed data — including GoodRx Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, GoodRx Holdings, Inc. (GDRX) stock price is $2.65. The stock is traded on NASDAQ under the ticker symbol GDRX. The 52-week range is $1.77 – $5.81.

GDRX stock priceGDRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice